Global Catheter Market Size, Share & Forecast 2025–2033
Market Overview
The Global Catheter Market was valued at USD 25.32 billion in 2024 and is projected to reach USD 51.65 billion by 2033, growing at a CAGR of 8.24% during the forecast period from 2025 to 2033. This market expansion is fueled by the rising incidence of chronic diseases, advancements in catheter technologies, a global aging population, and a growing preference for minimally invasive surgical procedures.
What is a Catheter?
A catheter is a thin, flexible medical device inserted into the body to perform various functions such as fluid drainage, drug delivery, and real-time physiological monitoring. Catheters are commonly made from silicone, plastic, or rubber and are essential in a wide range of medical specialties including cardiology, urology, neurology, nephrology, and oncology.
Key Growth Drivers
- Rising Burden of Chronic Diseases
The escalating prevalence of chronic conditions—such as cardiovascular disease, diabetes, chronic kidney disease, and cancer—is significantly driving catheter demand. Procedures like hemodialysis, cardiac catheterization, and chemotherapy often require catheter usage. According to the World Health Organization (WHO), non-communicable diseases are responsible for over 70% of global deaths annually, underscoring the importance of catheter-based interventions.
- Technological Innovations
The market is witnessing rapid advancements in catheter technologies. These include bioabsorbable catheters, antimicrobial-coated catheters, and devices with enhanced flexibility and steerability. For example, in September 2024, the launch of the EMBOGUARD™ Balloon Guide Catheter introduced new standards in thrombectomy by improving clot removal efficiency, reducing procedure times, and minimizing embolic risks.
- Surge in Minimally Invasive Procedures
The shift towards minimally invasive procedures has propelled catheter usage globally. These methods reduce hospital stay durations, postoperative complications, and healthcare costs. Catheters are instrumental in supporting such surgeries by enabling precise fluid delivery and drainage or supporting diagnostic imaging.
Regional Market Insights
Germany
Germany is a leading market within Europe, driven by its aging population and highly developed healthcare infrastructure. Catheter use is widespread in treating cardiovascular and urological disorders. Innovations such as Biotronik’s multifunctional peripheral catheter OSCAR, launched in June 2023, reinforce the country’s technological leadership.
China
China’s catheter market is growing rapidly, supported by strong healthcare reforms, a rising middle class, and increasing incidence of diabetes and cardiovascular diseases. The August 2023 approval of Novasight’s dual-mode intravascular imaging catheter marks a significant step in integrating cutting-edge technologies in Chinese hospitals.
Brazil
As Latin America’s largest economy, Brazil represents the region’s most promising catheter market. While infrastructure disparities remain, increased government investment and rising demand for minimally invasive procedures are fueling growth. The 2023 debut of Endovastec’s Reewarm™ PTX DCB Catheter underscores the country’s rising profile in the global catheter landscape.
United Arab Emirates (UAE)
In the Middle East, the UAE is emerging as a prominent catheter market due to its modern healthcare infrastructure and strategic emphasis on medical tourism. Lifestyle diseases like obesity, diabetes, and heart disease are on the rise, spurring catheter demand. In February 2024, Zylox-Tonbridge received UAE approvals for five new catheter-based devices, expanding the country’s high-tech medical offerings.
South Africa
South Africa leads the African catheter market. Increased public and private investment in medical technology, along with the country’s growing burden of kidney and heart diseases, are key growth factors. Coloplast’s launch of a new intermittent catheter in November 2022, focused on reducing UTI risks, highlights the market’s development trajectory.
Leading Companies and Strategic Developments
Abbott Laboratories
- February 2023: Received FDA approvals for the Sensor Enabled™ TactiFlex Ablation Catheter and FlexAbility Catheter.
- August 2021: The Amulet™ LAA Occluder demonstrated superior results in preventing stroke in AFib patients compared to Boston Scientific’s Watchman device.
Becton Dickinson and Company (BD)
- May 2023: Launched the BD PosiFlush SafeScrub, improving IV catheter maintenance.
- November 2023: Released a new ultrasound-guided vascular access system to enhance placement accuracy.
- Conducted a landmark study evaluating midline catheter effectiveness for blood draws—the first of its kind to be peer-reviewed.
Boston Scientific Corporation
- January 2024: FDA approved the FARAPULSE™ PFA System for atrial fibrillation treatment.
- March 2024: FDA granted approval for the AGENT™ Drug-Coated Balloon, targeting coronary in-stent restenosis.
- December 2022: Acquired a majority stake in Acotec Scientific, bolstering its presence in the Asia-Pacific market.
Teleflex Incorporated
- February 2023: Triumph™ Catheter secured FDA 510(k) approval; the GuideLiner® Coast™ Catheter debuted in Seattle.
- May 2023: Launched NaviCurve™ Stylet and Arrow® VPS Rhythm® DLX to enhance PICC insertion safety and speed.
- November 2023: Established a clinical registry for its MANTATM Vascular Closure Device for TAVR procedures.
Medtronic Plc.
- February 2022: Gained FDA approval for pediatric AVNRT cryoablation using the Freezor™ line of catheters.
- December 2023: Became the first firm to receive FDA approval for PulseSelect PFA System, usable in both paroxysmal and persistent AFib.
- March 2023: CE mark approval for the Affera™ Mapping and Ablation System with Sphere-9™ Catheter, supporting arrhythmia diagnosis and treatment.
New Publish Blogs :
Top Beta Glucan Companies Worldwide
New Publish Reports :
non lethal weapons market report
restaurant industry trends canada
Conclusion
The Global Catheter Market is undergoing a major transformation driven by an aging global population, rising chronic disease prevalence, and continuous innovation in catheter technology. Regional markets in China, Brazil, and the UAE are rapidly evolving, while established players like Germany and the U.S. continue to push the frontiers of technological innovation.
As healthcare systems worldwide emphasize better outcomes and cost-efficiency, catheters will remain at the heart of modern medical interventions. Market participants that invest in R&D, strategic partnerships, and emerging economies will be best positioned to lead this dynamic market through 2033 and beyond.
About Renub Research
Renub Research is a leading market research and consulting company offering management consulting and in-depth industry analysis across various sectors. With a global perspective and a local understanding, Renub Research delivers insights that matter.
About the Company:
Renub Research is a Market Research and Consulting Company. We have more than 15 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)
Email: mailto:[email protected]
